{"id":7456,"date":"2024-03-21T11:10:36","date_gmt":"2024-03-21T16:10:36","guid":{"rendered":"https:\/\/fifarma.org\/?p=7456"},"modified":"2024-05-17T11:57:01","modified_gmt":"2024-05-17T16:57:01","slug":"cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina","status":"publish","type":"post","link":"https:\/\/fifarma.org\/pt\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/","title":{"rendered":"Qual \u00e9 o tempo de espera para acessar novos medicamentos contra o c\u00e2ncer na Am\u00e9rica Latina?"},"content":{"rendered":"

Imagine-se em uma corrida pela sua vida, onde cada segundo conta. Essa \u00e9 a situa\u00e7\u00e3o para muitos pacientes na Am\u00e9rica Latina que dependem da chegada de medicamentos avan\u00e7ados para tratar o c\u00e2ncer ou doen\u00e7as raras. Sem d\u00favida, a espera por esses medicamentos pode ser longa e cheia de incertezas.
<\/p>\n\n\n\n

A luta contra o tempo no acesso a medicamentos oncol\u00f3gicos na Am\u00e9rica Latina<\/strong><\/h3>\n\n\n\n

Recentemente, a Federa\u00e7\u00e3o Latino-Americana da Ind\u00fastria Farmac\u00eautica (FIFARMA), em colabora\u00e7\u00e3o com a organiza\u00e7\u00e3o de pesquisa IQVIA<\/a>, publicou a segunda vers\u00e3o do estudo chamado Indicador FIFARMA W.A.I.T. 2023, sigla que significa \"Indicador de espera para acessar terapias inovadoras\"; um estudo que trouxe \u00e0 tona novos dados sobre os tempos de espera para acessar medicamentos inovadores para c\u00e2ncer e doen\u00e7as raras.<\/p>\n\n\n\n

Revelando dados com o Indicador FIFARMA W.A.I.T. 2023<\/strong><\/h3>\n\n\n\n

Em sua segunda edi\u00e7\u00e3o, este estudo analisa a disponibilidade e o tempo de acesso a 228 medicamentos para c\u00e2ncer e doen\u00e7as raras em oito pa\u00edses da Am\u00e9rica Latina (Argentina, Brasil, Chile, Col\u00f4mbia, Costa Rica, Equador, M\u00e9xico e Peru). As descobertas indicam que os pacientes podem esperar em m\u00e9dia entre 1,9 e 4,5 anos desde a aprova\u00e7\u00e3o desses medicamentos pela FDA (Administra\u00e7\u00e3o de Alimentos e Medicamentos dos EUA) at\u00e9 a disponibilidade efetiva em seus pa\u00edses.<\/p>\n\n\n\n

Isso significa que, se um medicamento contra o c\u00e2ncer for aprovado hoje nos Estados Unidos, pode n\u00e3o estar dispon\u00edvel para um paciente na Am\u00e9rica Latina at\u00e9 quatro anos depois. Isso pode ser muito, reduzindo a esperan\u00e7a de vida de milh\u00f5es de pacientes atuais e potenciais. <\/p>\n\n\n\n

Este atraso reflete a necessidade urgente de melhorar e agilizar os processos regulat\u00f3rios para acelerar a disponibilidade de terapias inovadoras em nossa regi\u00e3o.<\/p>\n\n\n\n

Abordando a lacuna no acesso a medicamentos na Am\u00e9rica Latina<\/strong><\/h3>\n\n\n\n

Dos 228 medicamentos estudados, apenas 130 est\u00e3o dispon\u00edveis em algum pa\u00eds da Am\u00e9rica Latina e, desses, apenas 86 est\u00e3o acess\u00edveis em todos os pa\u00edses analisados. Este dado destaca ainda mais a lacuna de acesso na regi\u00e3o e a necessidade de uma a\u00e7\u00e3o conjunta para enfrentar esse desafio.
<\/p>\n\n\n\n


N\u00fameros que falam: O tempo de espera em pa\u00edses espec\u00edficos<\/strong><\/p>\n\n\n\n

Na Col\u00f4mbia, por exemplo, desde que um medicamento \u00e9 aprovado pela FDA, os pacientes esperam cerca de 1.184 dias (um pouco mais de tr\u00eas anos) para que seja aprovado em seu pa\u00eds. E isso n\u00e3o \u00e9 tudo, depois h\u00e1 que somar mais 489 dias para que esteja realmente ao alcance de quem precisa. No M\u00e9xico, a situa\u00e7\u00e3o \u00e9 ainda mais prolongada: 210 dias para a primeira aprova\u00e7\u00e3o, seguidos por um surpreendente salto para 2.074 dias (um pouco mais de cinco anos) para alcan\u00e7ar a disponibilidade total.<\/p>\n\n\n\n

Este tipo de atraso pode ser devido a v\u00e1rios fatores, como os processos de aprova\u00e7\u00e3o em cada pa\u00eds, os sistemas de reembolso e outros aspectos administrativos que, embora necess\u00e1rios, acabam prolongando a espera.<\/p>\n\n\n\n

\"\"\/<\/figure>\n\n\n\n

Desafio na Am\u00e9rica Latina: Reduzir os tempos de espera para tratamentos contra o c\u00e2ncer<\/strong><\/h3>\n\n\n\n

A situa\u00e7\u00e3o \u00e9 cr\u00edtica, e embora esses n\u00fameros possam parecer desanimadores, tamb\u00e9m s\u00e3o um chamado \u00e0 a\u00e7\u00e3o. Este relat\u00f3rio n\u00e3o \u00e9 apenas para informar, mas para motivar uma mudan\u00e7a, para que todos colaboremos e busquemos solu\u00e7\u00f5es. Trata-se de melhorar a vida de milh\u00f5es de pessoas, garantindo-lhes acesso aos tratamentos mais recentes e eficazes sem ter que esperar anos.<\/p>\n\n\n\n

O Indicador FIFARMA W.A.I.T. 2023 mostra claramente o desafio pela frente na Am\u00e9rica Latina: reduzir os tempos de espera para os tratamentos inovadores contra o c\u00e2ncer e doen\u00e7as raras.<\/p>\n\n\n\n

Com esta informa\u00e7\u00e3o, podemos continuar incentivando esta conversa urgente para que as mudan\u00e7as necess\u00e1rias ocorram e, assim, dar esperan\u00e7a e salvar vidas. Lembre-se de que hoje ou amanh\u00e3, a qualquer momento da vida, todos somos pacientes. <\/p>\n\n\n\n

<\/p>\n\n\n\n

Se quiser conhecer mais detalhes do estudo, fa\u00e7a o download do Indicador FIFARMA W.A.I.T. 2023 aqui. <\/strong><\/p>\n\n\n\n

\n
Baixe aqui!<\/a><\/div>\n<\/div>\n\n
\n\n\t\t\n
    \n\t\t\t <\/ul>\n <\/div>","protected":false},"excerpt":{"rendered":"

    Exploramos el tiempo de espera para la disponibilidad de medicamentos contra el c\u00e1ncer en Am\u00e9rica Latina y c\u00f3mo FIFARMA busca mejorar el acceso a terapias innovadoras.<\/p>","protected":false},"author":24,"featured_media":7457,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"enableOnePageScrollInPage":false,"onePageScrollCss":"","onePageScrollSpeed":1000,"onePageScrollAnimation":"easeInOutQuad","onePageScrollShowDotNavigation":true,"onePageScrollNavigation":"scaleUp","onePageScrollNavigationPosition":"right","onePageScrollNavigationHorizontal":[],"onePageScrollNavigationVertical":[],"onePageScrollNavigationSpacing":[],"onePageScrollNavigationColor":"#00ff0d","onePageScrollNavigationColorHover":"#00ff0d","onePageScrollNavigationColorActive":"#00ff0d","onePageScrollNavigationIcon":[],"onePageScrollNavigationWidth":[],"onePageScrollNavigationWidthHover":[],"onePageScrollNavigationWidthActive":[],"onePageScrollNavigationHeight":[],"onePageScrollNavigationHeightHover":[],"onePageScrollNavigationHeightActive":[],"onePageScrollNavigationBorder":[],"onePageScrollNavigationBorderHover":[],"onePageScrollNavigationBorderActive":[],"onePageScrollNavigationBorderRadius":[],"onePageScrollNavigationBorderRadiusHover":[],"onePageScrollNavigationBorderRadiusActive":[],"onePageScrollNavigationTooltipTypography":[],"onePageScrollNavigationTooltipColor":"#ffffff","onePageScrollNavigationTooltipColorHover":"","onePageScrollNavigationTooltipBgColor":"#00ff0d","onePageScrollNavigationTooltipBgColorHover":"","onePageScrollNavigationTooltipPadding":[],"onePageScrollNavigationTooltipPaddingHover":[],"onePageScrollNavigationTooltipBorderRadius":[],"onePageScrollNavigationTooltipBorderRadiusHover":[],"pageSettingsCustomCss":"","footnotes":""},"categories":[153,8,7,140],"tags":[98,125,126,123,133,122],"class_list":["post-7456","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-acceso","category-innovacion","category-salud","category-vacunas","tag-acceso","tag-cancer-2","tag-enfermedades-raras","tag-iqvia","tag-salud-en-latam","tag-w-a-i-t-indicator"],"yoast_head":"\n\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina? - FIFARMA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fifarma.org\/pt\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?\" \/>\n<meta property=\"og:description\" content=\"Exploramos el tiempo de espera para la disponibilidad de medicamentos contra el c\u00e1ncer en Am\u00e9rica Latina y c\u00f3mo FIFARMA busca mejorar el acceso a terapias innovadoras.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fifarma.org\/pt\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/\" \/>\n<meta property=\"og:site_name\" content=\"FIFARMA\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-21T16:10:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-17T16:57:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1597\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"fifarmacomunicaciones\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"fifarmacomunicaciones\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/\"},\"author\":{\"name\":\"fifarmacomunicaciones\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\"},\"headline\":\"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?\",\"datePublished\":\"2024-03-21T16:10:36+00:00\",\"dateModified\":\"2024-05-17T16:57:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/\"},\"wordCount\":734,\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/pexels-julie-viken-593451-scaled.jpg\",\"keywords\":[\"acceso\",\"C\u00e1ncer\",\"Enfermedades raras\",\"IQVIA\",\"Salud en LATAM\",\"W.A.I.T. Indicator\"],\"articleSection\":[\"Acceso\",\"Innovaci\u00f3n\",\"Salud\",\"Vacunas\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/\",\"name\":\"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina? - FIFARMA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/pexels-julie-viken-593451-scaled.jpg\",\"datePublished\":\"2024-03-21T16:10:36+00:00\",\"dateModified\":\"2024-05-17T16:57:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/pexels-julie-viken-593451-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2024\\\/03\\\/pexels-julie-viken-593451-scaled.jpg\",\"width\":2560,\"height\":1597},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/fifarma.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#website\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"name\":\"FIFARMA\",\"description\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"publisher\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fifarma.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#organization\",\"name\":\"Fifarma\",\"alternateName\":\"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica\",\"url\":\"https:\\\/\\\/fifarma.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"contentUrl\":\"https:\\\/\\\/fifarma.org\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/logo-fifarma.png\",\"width\":195,\"height\":39,\"caption\":\"Fifarma\"},\"image\":{\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fifarma.org\\\/#\\\/schema\\\/person\\\/f1731f7484686defa417316a8fe42068\",\"name\":\"fifarmacomunicaciones\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g\",\"caption\":\"fifarmacomunicaciones\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina? - FIFARMA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fifarma.org\/pt\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/","og_locale":"pt_BR","og_type":"article","og_title":"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?","og_description":"Exploramos el tiempo de espera para la disponibilidad de medicamentos contra el c\u00e1ncer en Am\u00e9rica Latina y c\u00f3mo FIFARMA busca mejorar el acceso a terapias innovadoras.","og_url":"https:\/\/fifarma.org\/pt\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/","og_site_name":"FIFARMA","article_published_time":"2024-03-21T16:10:36+00:00","article_modified_time":"2024-05-17T16:57:01+00:00","og_image":[{"width":2560,"height":1597,"url":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg","type":"image\/jpeg"}],"author":"fifarmacomunicaciones","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"fifarmacomunicaciones","Est. tempo de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#article","isPartOf":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/"},"author":{"name":"fifarmacomunicaciones","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068"},"headline":"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?","datePublished":"2024-03-21T16:10:36+00:00","dateModified":"2024-05-17T16:57:01+00:00","mainEntityOfPage":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/"},"wordCount":734,"publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"image":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg","keywords":["acceso","C\u00e1ncer","Enfermedades raras","IQVIA","Salud en LATAM","W.A.I.T. Indicator"],"articleSection":["Acceso","Innovaci\u00f3n","Salud","Vacunas"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/","url":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/","name":"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina? - FIFARMA","isPartOf":{"@id":"https:\/\/fifarma.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#primaryimage"},"image":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#primaryimage"},"thumbnailUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg","datePublished":"2024-03-21T16:10:36+00:00","dateModified":"2024-05-17T16:57:01+00:00","breadcrumb":{"@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#primaryimage","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2024\/03\/pexels-julie-viken-593451-scaled.jpg","width":2560,"height":1597},{"@type":"BreadcrumbList","@id":"https:\/\/fifarma.org\/cual-es-el-tiempo-de-espera-para-acceder-a-los-nuevos-medicamentos-para-el-cancer-en-america-latina\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/fifarma.org\/"},{"@type":"ListItem","position":2,"name":"\u00bfCu\u00e1l es el tiempo de espera para acceder a los nuevos medicamentos para el c\u00e1ncer en Am\u00e9rica Latina?"}]},{"@type":"WebSite","@id":"https:\/\/fifarma.org\/#website","url":"https:\/\/fifarma.org\/","name":"FIFARMA","description":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","publisher":{"@id":"https:\/\/fifarma.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fifarma.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/fifarma.org\/#organization","name":"Fifarma","alternateName":"Federaci\u00f3n Latinoamericana de la Industria Farmac\u00e9utica","url":"https:\/\/fifarma.org\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/","url":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","contentUrl":"https:\/\/fifarma.org\/wp-content\/uploads\/2022\/10\/logo-fifarma.png","width":195,"height":39,"caption":"Fifarma"},"image":{"@id":"https:\/\/fifarma.org\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fifarma.org\/#\/schema\/person\/f1731f7484686defa417316a8fe42068","name":"fifarmacomunicaciones","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8af54b74d81934872c5e9bf852bec4021ca6d3043cf2132e25087b2d09318d1c?s=96&d=mm&r=g","caption":"fifarmacomunicaciones"}}]}},"_links":{"self":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts\/7456","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/comments?post=7456"}],"version-history":[{"count":0,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/posts\/7456\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media\/7457"}],"wp:attachment":[{"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/media?parent=7456"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/categories?post=7456"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fifarma.org\/pt\/wp-json\/wp\/v2\/tags?post=7456"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}